Regulation of Tumor Necrosis Factor-Alpha Gene Expression in the Astrocyte

  • Il Yup Chung
  • Jong Bum Kwon
  • Etty N. Benveniste
Part of the Altschul Symposia Series book series (ALSS, volume 2)

Abstract

Tumor necrosis factor-alpha (TNF-α) is a pleiotropic cytokine with a diverse variety of biological functions on a wide range of cells (for review see Beutler and Cerami 1989; Vilcek and Lee 1991). TNF-α has especially been recognized as being one of the proinflammatory cytokines in a number of tissues, including the brain. Astrocytes, the most abundant glial cell in the brain, have been shown to be capable of producing many cytokines upon stimulation, including TNF-α (for review see Benveniste 1992). TNF-α is an important mediator of both inflammatory and immunological responses in the brain due to its interaction with astrocytes. TNF-α mediated responses include: 1) enhancement of ICAM-1 on human fetal astrocytes (Frohman et al. 1989); 2) enhancement of class II major histocompatibility complex (MHC) expression on astrocytes through its synergistic interaction with interferon-gamma (IFN-γ) or virus (Massa et al. 1987; Benveniste et al. 1989); 3) proliferation of adult astrocytes (Selmaj et al. 1990); and 4) induction of interleukin-6 (IL-6) production by astrocytes (Frei et al. 1989; Benveniste et al. 1990). Additionally, TNF-α may act as an autocrine regulator of astrocyte function as these cells both produce TNF-α (Robbins et al. 1987; Lieberman et al. 1989; Chung and Benveniste 1990) and express high affinity TNF-α receptors (Benveniste et al. 1989). TNF-α may also contribute to demyelination within the central nervous system (CNS) due to its ability to lyse oligodendrocytes, the myelin producing cell in the CNS (Robbins et al. 1987), and induce myelin damage (Selmaj and Raine 1988).

Keywords

Experimental Allergic Encephalomyelitis Human Fetal Astrocyte Tumor Necrosis Factor Gene Expression Human Astroglioma Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Asano T and H Hidaka, 1984, Vasodilatory action of HA 1004 (N-(2-guanidimethyl) -5isoquinolinesulfonamide}, a novel calcium antagonist with no effect on cardiac function., J. Pharmacol. Exp. Ther. 231: 141–145.PubMedGoogle Scholar
  2. Benveniste EN, 1992, Cytokines: Influence on glial cell gene expression and function, in: “Chemical Immunology: Neuroimmunoendocrinology”, J. E. Blalock, ed., (S. Karger, Basel ), Vol. 52, 106–153.Google Scholar
  3. Benveniste EN, SM Sparacio and JR Bethea, 1989, Tumor necrosis factor-a enhances interferon y mediated Class II antigen expression on astrocytes, J. Neuroimmunol. 25: 209–219.PubMedCrossRefGoogle Scholar
  4. Benveniste EN, SM Sparacio, JG Norris, HE Grenett and GM Fuller, 1990, Induction and regula- tion of interleukin-6 gene expression in rat astrocytes, J. Neuroimmunol. 30: 201–212.PubMedCrossRefGoogle Scholar
  5. Bethea JR, IY Chung, SM Sparacio, GY Gillespie and EN Benveniste, 1992a, Interleukin-lß induction of tumor necrosis factor-alpha gene expression in human astroglioma cells, J. Neuroimmunol. 36: 179–191.CrossRefGoogle Scholar
  6. Bethea JR, GY Gillespie and EN Benveniste, 1992b, Interleukin-113 induction of TNF-a gene expression: Involvement of protein kinase C, J. Cell. Physiol. 152: 264–273.PubMedCrossRefGoogle Scholar
  7. Beutler B and A Cerami, 1987, Cachectin: More than a tumor necrosis factor, New Engl. J. Med. 316: 379–385.PubMedCrossRefGoogle Scholar
  8. Beutler B and A Cerami, 1989, The biology of cachectin/INF-A primary mediator of the host response, Ann.Rev. /mmunol. 7: 625–655.CrossRefGoogle Scholar
  9. Beutler BA, IW Milsark and A Cerami, 1985, Cachectin/tumor necrosis factor: Production, distribution, and metabolic fate in vivo, J. Immunol. 135: 3972–3977.PubMedGoogle Scholar
  10. Brett J, H Gerlach, P Nawroth, S Steinberg, G Godman and D Stern, 1989, Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins, J.Exp. Med. 169: 1977–1991.PubMedCrossRefGoogle Scholar
  11. Celada A and RA Maki, 1991, IFN-’y induced the expression of the genes for MHC class II I-Aß and tumor necrosis factor through a protein kinase C-independent pathway, J. Immunol. 146: 114–120.PubMedGoogle Scholar
  12. Chantry D, M Turner, E Abney and M Feldmann, 1989, Modulation of cytokine production by transforming growth factor ß, J. Immunol. 142: 4295–4300.PubMedGoogle Scholar
  13. Chung IY and EN Benveniste, 1990, Tumor necrosis factor-alpha production by astrocytes: Induction by lipopolysaccharide, interferon-gamma and interleuldn-1, J. Immunol. 144: 2999–3007.PubMedGoogle Scholar
  14. Chung IY, JG Norris and EN Benveniste, 1991, Differential TNF-a expression by astrocytes from experimental allergic encephalomyelitis susceptible and resistant rat strains., J. Exp. Med. 173: 801–811.PubMedCrossRefGoogle Scholar
  15. Descoteaux A and G Matlashewski, 1990, Regulation of tumor necrosis factor gene expression and protein synthesis in murine macrophages treated with recombinant tumor necrosis factor, J. Immunol. 145: 846–853.PubMedGoogle Scholar
  16. Frei K, UV Malipiero, TP Leist, RM Zinkernagel, ME Schwab and A Fontana, 1989, On the cellular source and function of interleukin-6 produced in the central nervous system in viral diseases, Eur. J. Immunol. 19: 689–694.PubMedCrossRefGoogle Scholar
  17. Frei K, C Siepl, P Groscurth, S Bodmer, C Schwerdel and A Fontana, 1987, Antigen presentation and tumor cytotoxicity by interferon-y-treated microglial cells, Eur. J. Immunol. 17: 1271–1278.PubMedCrossRefGoogle Scholar
  18. Frohman EM, TC Frohman, ML Dustin, B Vayuvegula, B Choi, A Gupta, S van den Noort and S Gupta, 1989, The induction of intracellular adhesion molecule 1 (ICAM 1) expression on human fetal astrocytes by interferon-y, tumor necrosis factor-a, lymphotoxin, and interleukin-l: relevance to intracerebral antigen presentation, J. Neuroimmunol. 23: 117–124.PubMedCrossRefGoogle Scholar
  19. Hidaka H, M Inagaki, S Kawamoto and Y Sasaki, 1984, Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C, Biochemistry 23: 5036–5041.PubMedCrossRefGoogle Scholar
  20. Hofman FM, DR Hinton, K Johnson and JE Merrill, 1989, Tumor necrosis factor identified in multiple sclerosis brain, J. Exp. Med. 170: 607–612.PubMedCrossRefGoogle Scholar
  21. Horiguchi J, D Spriggs, K Imamura, R Stone, R Luebbers and D Kufe, 1989, Role of arachidonic acid metabolism in transcriptional induction of tumor necrosis factor gene expression by phorbol ester, Mol. Cell. Biol. 9: 252–258.PubMedGoogle Scholar
  22. Jongeneel CV, 1992, The TNF and lymphotoxin promoters, in: “Tumor Necrosis Factor. The Molecules and Their Emerging Role in Medicine”, B. Beutler, ed., Raven Press, New York, 539–559.Google Scholar
  23. Kovacs EJ, D Radzioch, HA Young and L Varesio, 1988, Differential inhibition of IL-1 and TNF-a mRNA expression by agents which block second messenger pathways in murine macrophages, J. Immunol. 141: 3101–3105.PubMedGoogle Scholar
  24. Lieberman AP, PM Pitha, HS Shin and ML Shin, 1989, Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus, Proc. Natl. Acad. Sci. USA 86: 6348–6352.PubMedCrossRefGoogle Scholar
  25. Lieberman AP, PM Pitha and ML Shin, 1990, Protein kinase regulates tumor necrosis factor mRNA stability in virus-stimulated astrocytes, J. Exp. Med. 172: 989–992.PubMedCrossRefGoogle Scholar
  26. Lieberman AP, PM Pitha and ML Shin, 1992, Poly(A) removal is the kinase-regulated step in tumor necrosis factor mRNA decay, J. Biol. Chem. 267: 2123–2126.PubMedGoogle Scholar
  27. Massa PT, A Schmipl, E Wecker and V ter Meulen, 1987, Tumor necrosis factor amplifies virus-mediated la induction on astrocytes, Proc. Natl. Acad. Sci. USA 84: 7242–7245.PubMedCrossRefGoogle Scholar
  28. Mohri M, DR Spriggs and D Kufe, 1990, Effects of lipopolysaccharide on phopholipase A2 activity and tumor necrosis factor expression in HL-60 cells, J. Immunol. 144: 2678–2682.PubMedGoogle Scholar
  29. Pohlman TH, KA Stanness, PG Beatty, HD Ochs and JM Harlan, 1986, An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherance by a cd18-dependent mechanism, J. Immunol. 136: 4548–4553.PubMedGoogle Scholar
  30. Robbins DS, Y Shirazi, BE Drysdale, A Lieberman, HS Shin and ML Shin, 1987, Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes, J. Immunol. 139: 2593–2597.PubMedGoogle Scholar
  31. Ruddle NH, CM Bergman, KM McGrath, EG Lingenheld, ML Grunnet, SJ Padula and RB Clark, 1990, An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis, J. Exp. Med. 172: 1193–1200.PubMedCrossRefGoogle Scholar
  32. Selmaj K, CS Raine, B Cannella and CF Brosnan, 1991, Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions, J. Clin. Invest. 87: 949–954.PubMedCrossRefGoogle Scholar
  33. Selmaj KW, M Farooq, WT Norton, CS Raine and CF Brosnan, 1990, Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor, J. Immunol. 144: 129–135.PubMedGoogle Scholar
  34. Selmaj KW and CS Raine, 1988, Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro., Ann. Neurol. 23: 339–346.PubMedCrossRefGoogle Scholar
  35. Sherman ML, R Datta, DE Hallahan, RR Weichselbaum and DW Kufe, 1991, Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes, J.Clin. Invest. 87: 1794–1797.PubMedCrossRefGoogle Scholar
  36. Tamaoki T, H Nomoto, I Takahashi, Y Kato, M Morimoto and F Tornita, 1986, Staurosporine, a potent inhibitor of phospholipid/Ca++ dependent protein kinase, Biochem. Biophys. Res. Commun. 135: 397–402.PubMedCrossRefGoogle Scholar
  37. Trede NS, RS Geha and T Chatila, 1991, Transcriptional activation of IL-lß and tumor necrosis factor-a genes by MHC class II ligands, J. Immunol. 146: 2310–2315.PubMedGoogle Scholar
  38. Vilcek J and TH Lee, 1991, Tumor necrosis factor, J. Biol. Chem. 266: 7313–7316.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Il Yup Chung
    • 1
  • Jong Bum Kwon
    • 1
  • Etty N. Benveniste
    • 1
  1. 1.Department of Cell BiologyUniversity of Alabama at BirminghamBirminghamUSA

Personalised recommendations